Crestwood Advisors Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Buy
115,212
+11,283
+11% +$1.3M 0.23% 83
2025
Q4
$10.9M Sell
103,929
-1,844
-2% -$173K 0.18% 98
2025
Q3
$8.88M Sell
105,773
-4,673
-4% -$385K 0.15% 109
2025
Q2
$8.74M Buy
110,446
+695
+0.6% +$55.2K 0.16% 111
2025
Q1
$9.85M Sell
109,751
-7,120
-6% -$665K 0.19% 97
2024
Q4
$11.6M Sell
116,871
-5,896
-5% -$608K 0.22% 85
2024
Q3
$13.9M Buy
122,767
+392
+0.3% +$46.6K 0.27% 77
2024
Q2
$15.1M Buy
122,375
+1,546
+1% +$199K 0.31% 73
2024
Q1
$15.9M Buy
120,829
+2,814
+2% +$347K 0.35% 70
2023
Q4
$12.9M Sell
118,015
-2,903
-2% -$301K 0.3% 72
2023
Q3
$12.4M Buy
120,918
+12,281
+11% +$1.32M 0.33% 74
2023
Q2
$12.5M Sell
108,637
-56,809
-34% -$6.45M 0.39% 60
2023
Q1
$17.6M Sell
165,446
-4,994
-3% -$539K 0.59% 53
2022
Q4
$18.9M Sell
170,440
-36,452
-18% -$3.73M 0.64% 51
2022
Q3
$17.8M Buy
206,892
+988
+0.5% +$88.2K 0.63% 52
2022
Q2
$18.8M Buy
205,904
+1,166
+0.6% +$103K 0.63% 56
2022
Q1
$16.8M Sell
204,738
-4,154
-2% -$328K 0.47% 60
2021
Q4
$16M Sell
208,892
-5,980
-3% -$476K 0.42% 62
2021
Q3
$16.1M Sell
214,872
-9,033
-4% -$687K 0.46% 63
2021
Q2
$17.4M Buy
223,905
+385
+0.2% +$28.6K 0.5% 61
2021
Q1
$16.4M Sell
223,520
-2,331
-1% -$172K 0.52% 61
2020
Q4
$17.6M Buy
225,851
+47,327
+27% +$3.62M 0.58% 57
2020
Q3
$14.1M Sell
178,524
-1,395
-0.8% -$109K 0.53% 59
2020
Q2
$13.3M Buy
179,919
+29,627
+20% +$2.23M 0.53% 61
2020
Q1
$11M Buy
150,292
+1,416
+1% +$111K 0.55% 58
2019
Q4
$12.9M Buy
148,876
+2,445
+2% +$201K 0.51% 57
2019
Q3
$11.8M Buy
146,431
+10,312
+8% +$826K 0.52% 61
2019
Q2
$10.9M Buy
136,119
+125,021
+1,127% +$9.57M 0.49% 66
2019
Q1
$881K Buy
11,098
+1,345
+14% +$101K 0.06% 85
2018
Q4
$711K Sell
9,753
-688
-7% -$48.6K 0.06% 90
2018
Q3
$707K Hold
10,441
0.05% 89
2018
Q2
$665K Sell
10,441
-555
-5% -$31.3K 0.05% 89
2018
Q1
$571K Sell
10,996
-1,467
-12% -$79.2K 0.04% 94
2017
Q4
$669K Sell
12,463
-898
-7% -$49.8K 0.05% 91
2017
Q3
$816K Buy
13,361
+614
+5% +$37.2K 0.07% 81
2017
Q2
$780K Sell
12,747
-198
-2% -$12.1K 0.07% 82
2017
Q1
$774K Buy
12,945
+146
+1% +$8.86K 0.07% 80
2016
Q4
$719K Buy
12,799
+754
+6% +$44.1K 0.07% 84
2016
Q3
$717K Sell
12,045
-163
-1% -$9.53K 0.09% 68
2016
Q2
$671K Sell
12,208
-210
-2% -$11.2K 0.08% 69
2016
Q1
$627K Sell
12,418
-2,696
-18% -$132K 0.07% 79
2015
Q4
$762K Buy
15,114
+1,573
+12% +$79.3K 0.09% 82
2015
Q3
$638K Sell
13,541
-2,824
-17% -$150K 0.08% 79
2015
Q2
$889K Buy
16,365
+3,286
+25% +$184K 0.12% 67
2015
Q1
$717K Sell
13,079
-303
-2% -$17.2K 0.1% 66
2014
Q4
$725K Sell
13,382
-534
-4% -$29.8K 0.11% 65
2014
Q3
$787K Buy
13,916
+21
+0.2% +$1.18K 0.12% 61
2014
Q2
$767K Buy
13,895
+63
+0.5% +$3.44K 0.12% 59
2014
Q1
$749K Sell
13,832
-427
-3% -$22.1K 0.12% 60
2013
Q4
$681K Sell
14,259
-379
-3% -$17.3K 0.11% 63
2013
Q3
$665K Buy
14,638
+943
+7% +$43.1K 0.12% 60
2013
Q2
$607K Buy
+13,695
New +$612K 0.11% 63

Other funds holding MRK

Crestwood Advisors Group's MRK Position: Q1 2026 in Review

Crestwood Advisors Group increased its Merck (MRK) stake by 11% in Q1 2026, buying an estimated $1.3M and bringing the position to 115,212 shares worth $13.9M. The position accounts for 0.23% of the portfolio, ranked #83.

Crestwood Advisors Group first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.9M in Q4 2022. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Crestwood Advisors Group held 115,212 shares of Merck worth $13.9M as of Q1 2026.
  • Crestwood Advisors Group bought 11,283 Merck shares in Q1 2026, an estimated $1.3M.
  • Merck made up 0.23% of Crestwood Advisors Group's portfolio in Q1 2026, its #83 holding.
  • Crestwood Advisors Group first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Crestwood Advisors Group's Merck position peaked at $18.9M in Q4 2022.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.